Literature DB >> 30025124

Trichostatin A Ameliorates Conjunctival Fibrosis in a Rat Trabeculectomy Model.

Mi Sun Sung1, Gwang Hyeon Eom2, Soo Jin Kim1, So Young Kim1, Hwan Heo1, Sang Woo Park1,3.   

Abstract

Purpose: To investigate whether histone deacetylase (HDAC) activity is associated with postoperative scarring and to evaluate the effect of HDAC inhibition by topical trichostatin A (TSA) on conjunctival fibrosis after trabeculectomy in a rat model.
Methods: Trabeculectomy was performed on the left eye of Sprague-Dawley rats. In the first experiment, adenoviruses HDAC 1, HDAC 2, and green fluorescent protein were added to the subconjunctival space during trabeculectomy. Expression of α-smooth muscle actin (α-SMA) was evaluated. In the second experiment, rats undergoing trabeculectomy were randomized into control, vehicle control, steroid, 500 nmol/L TSA, and 1 μmol/L TSA groups. On postoperative day 14, bleb vascularity, toxic effect of topical TSA on corneal epithelium, expression of α-SMA, transforming growth factor (TGF)-β1, and phosphorylated-Smad2/3 and the infiltration of CD45+ cells were determined. Masson's trichrome staining and immunofluorescence staining for α-SMA and CD45 were also performed.
Results: Overexpression of HDAC1 contributed to accelerated conjunctival fibrosis after trabeculectomy. HDAC inhibition by topical administration of 1 μmol/L TSA significantly decreased bleb vascularity, leukocyte infiltration, and expression of α-SMA and TGF-β1 in the conjunctiva. Its effectiveness on conjunctival fibrosis was comparable to that of topical steroid. Masson's trichrome staining showed decreased collagen deposition in the bleb tissues of steroid and 1 μmol/L TSA treatment groups. Topical TSA did not have any toxic effect on the corneal epithelium. Conclusions: HDAC activity is involved in postoperative conjunctival fibrosis. HDAC inhibition by topical administration of TSA eye drops is a safe and effective therapeutic modality to modulate wound healing after trabeculectomy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30025124     DOI: 10.1167/iovs.18-23826

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  [Anti-scarring effect of rapamycin in rabbits following glaucoma filtering surgery].

Authors:  Xin Kang; Ying Shen; Haixia Zhao; Zhaoge Wang; Wenying Guan; Ruichun Ge; Ruifang Wang; Xue Tai
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-11-30

Review 2.  Molecular mechanisms and treatments for ocular symblephara.

Authors:  Aditi Swarup; Christopher N Ta; Albert Y Wu
Journal:  Surv Ophthalmol       Date:  2021-04-29       Impact factor: 6.048

3.  The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model.

Authors:  Mor Dahbash; Ruti Sella; Elinor Megiddo-Barnir; Yael Nisgav; Nataly Tarasenko; Dov Weinberger; Ada Rephaeli; Tami Livnat
Journal:  Int J Mol Sci       Date:  2019-02-07       Impact factor: 5.923

4.  PNP Hydrogel Prevents Formation of Symblephara in Mice After Ocular Alkali Injury.

Authors:  Aditi Swarup; Abigail K Grosskopf; Lindsay M Stapleton; Varun R Subramaniam; BaoXiang Li; Irving L Weissman; Eric A Appel; Albert Y Wu
Journal:  Transl Vis Sci Technol       Date:  2022-02-01       Impact factor: 3.283

5.  Histone Deacetylases Regulation by δ-Opioids in Human Optic Nerve Head Astrocytes.

Authors:  Syed A H Zaidi; Nakul Thakore; Sudha Singh; Wendy Guzman; Shikhar Mehrotra; Vamsi Gangaraju; Shahid Husain
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

6.  HDAC2 Regulates Glial Cell Activation in Ischemic Mouse Retina.

Authors:  Mi Sun Sung; Hwan Heo; Gwang Hyeon Eom; So Young Kim; Helong Piao; Yue Guo; Sang Woo Park
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

7.  AR12286 Alleviates TGF-β-Related Myofibroblast Transdifferentiation and Reduces Fibrosis after Glaucoma Filtration Surgery.

Authors:  Wen-Sheng Cheng; Ching-Long Chen; Jiann-Torng Chen; Le-Tien Lin; Shu-I Pao; Yi-Hao Chen; Da-Wen Lu
Journal:  Molecules       Date:  2020-09-26       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.